heXembio

heXembio is a biotech company in New York, United States, founded in 2024. It has raised $17.9M across 2 rounds, most recently a $10.4M Seed in April 2026.

Recoding early human development for longevity

Headquarters
New York, New York
Employees
1–10
Founded
2024
Business Model
B2B
Website
hexemb.io
Total Funding
$17.9M
Last Round
$10.4M SeedApr 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 8 investors for this company. The full record is or through the API.

About

heXembio is a longevity therapeutics company developing the world's first rejuvenated hematopoietic stem cell therapy. Its platform restores the regenerative power of aged blood stem cells using a synthetic biology approach validated in peer-reviewed research published in Nature. The technology targets aging, immune health, and hematological conditions.

Summary

It lists 1–10 employees. It has raised $17.9M in total across 2 rounds, most recently a $10.4M Seed round in Apr 2026. Investors include Draper Associates, SOSV and Zentynel.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedApr 2026
$10.4M

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

heXembio on Indexed.vc
<a href="https://indexed.vc/companies/hexembio"><img src="https://indexed.vc/api/badge/company/hexembio" alt="heXembio on Indexed.vc" width="260" height="76" /></a>